Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis, and retrospective study
Abstract: Antiangiogenic agents, including vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs), represent an important class of treatments for a range of solid tumors. However, concerns have arisen over potential associations between antiangiogenic agents and thromb...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-01-01
|
| Серія: | Blood Advances |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2473952925006238 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|